A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT

Accounting for multiple comparisons in a genome-wide association study (GWAS)

(2011) Randall C Johnson et al.   BMC GENOMICS

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

(2011) Eric J Peters et al.   PHARMACOGENOMICS

A comparison of association methods for cytotoxicity mapping in pharmacogenomics

(2011) Chad Brown   Frontiers in Genetics

Temozolomide: Mechanisms of Action, Repair and Resistance

(2011) Jihong Zhang et al.   Current Molecular Pharmacology

LocusZoom: regional visualization of genome-wide association scan results

(2010) R. J. Pruim et al.   BIOINFORMATICS

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations

(2010) Mathew J. Barber et al.   PLoS One

Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS

(2010) Dan L. Nicolae et al.   PLoS Genetics

Genotype Imputation

(2009) Yun Li et al.   Annual Review of Genomics and Human Genetics

SCAN: SNP and copy number annotation

(2009) Eric R. Gamazon et al.   BIOINFORMATICS

Pharmacogenomic Discovery Using Cell-Based Models

(2009) M. Welsh et al.   PHARMACOLOGICAL REVIEWS

Evaluation of Genetic Variation Contributing to Differences in Gene Expression between Populations

(2008) Wei Zhang et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin

(2008) Marisa Wong Medina et al.   CIRCULATION

Identification of genomic regions contributing to etoposide-induced cytotoxicity

(2008) Wasim K. Bleibel et al.   HUMAN GENETICS

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

(2008) Monika E. Hegi et al.   JOURNAL OF CLINICAL ONCOLOGY